Photo from academic.microsoft.com
It is controversial whether the use of biological disease‐modifying antirheumatic drugs (DMARDs) increases the risk of herpes zoster (HZ). We aimed to evaluate the risks of HZ in tumor necrosis… Click to show full abstract
It is controversial whether the use of biological disease‐modifying antirheumatic drugs (DMARDs) increases the risk of herpes zoster (HZ). We aimed to evaluate the risks of HZ in tumor necrosis factor inhibitor (TNFI) and non‐TNFI users with rheumatoid arthritis (RA) over 3 years in Japan.
Keywords:
inhibitor;
herpes zoster;
tnf inhibitor;
rheumatoid arthritis;
risk herpes;
users rheumatoid
Journal Title: International Journal of Rheumatic Diseases
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Rheumatic Diseases
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!